.jpg)
“耀杰不凡”致敬幕后抗疫英雄推文解读活动
第三刊：流感样病例获关注，新冠与呼吸道病原鉴别成关键！
本期分享的内容正是武汉疾控中心病原生物检验所副所长刘满清所带领的团队做出的成果，研究重新分析了2019年10月6日至2020年1月21日在武汉市收集的640份流感样病例的咽拭子检测结果。团队通过使用上海伯杰医疗的新冠检测试剂，检测出了9例新冠阳性病例。经综合分析知，在2020年1月上旬，新冠已经在武汉社区内传播，并且这些病人混合在流感样病例当中。
参考文献：
1. Coronavirus Disease 2019 (COVID-19) Situation Report 33 (World Health Organization, 2020).
2. Gorbalenya, A. E. et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
3. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of
probable bat origin. Nature 579, 270–273 (2020).
4. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China,
2019. N. Engl. J. Med. 382, 727–733 (2020).
5. Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
6. Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514–523 (2020).
7. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020. China CDC Weekly 2, 113–122 (2020).
8. Epidemic Update and Risk Assessment of 2019 Novel Coronavirus (Chinese Center for Disease Control and Prevention, 2020).
9. Yang, P. et al. Review of an influenza surveillance system, Beijing, People’s Republic of China. Emerg. Infect. Dis. 15, 1603–1608 (2009).
10. Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061–1069 (2020).
11. Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel
coronavirus-infected pneumonia. N. Engl. J. Med. 323, 1199–1207 (2020).
12. Wu, J. T., Leung, K. & Leung, G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 395, 689–697 (2020).
13. Li, L. & Fu, H. China’s health care system reform: progress and prospects.
Int. J. Health Plann. Manage. 32, 240–253 (2017).
14. Wang, M. et al. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. Preprint at medRxiv https://doi. org/10.1101/2020.02.12.20022327 (2020).
15. Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of
infected patients. N. Engl. J. Med. 382, 1177–1179 (2020).
16. Shi, W. et al. Co-circulation and persistence of multiple A/H3N2 influenza
variants in China. Emerg. Microbes Infect. 8, 1157–1167 (2019).
17. Peng, J. et al. The epidemiology and etiology of influenza-like illness in Chinese children from 2008 to 2010. J. Med. Virol. 84, 672–678 (2012).
上海伯杰医疗科技有限公司是一家致力于感染性病原体分子诊断试剂研发和应用，深耕于多重荧光PCR诊断试剂和痕量病毒二代测序试剂及相关服务的国家高新技术企业。公司围绕感染性病原体这一主线，从诊断试剂、诊断仪器、测序服务和医检所服务等多个面提供全套解决方案。公司秉承“勇于创新，质量为先”的方针，为医疗机构、疾控公卫、高校科研等合作伙伴提供优质产品与服务。
全国客服电话：400-860-3688